Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing Novo Nordisk’s patent RU 2421238. On September 30, 2024
Starting October 5, 2024, significant changes will take effect in Russia’s patent fee structure, following Resolution No. 1278 of September 27, 2024 by the Government of the Russian
During the industry conference “Book Market of Russia – 2024” at the Moscow International Book Fair, Evgeny Zaitsev, the head of the Department for Control and Supervision
On August 8, 2024, the Patent Disputes Chamber of Rospatent upheld AstraZeneca’s objection to the validity of the Eurasian Patent No. 40996 for the medication Osimertinib by
Your Name E-mail Phone Message
Agreed with privacy policy
Our specialists will revert to you soon. Thank you for contacting us!
Мы обязательно рассмотрим его в ближайшее время и дадим Вам ответ
